A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3‐rearranged renal cell carcinoma

MLA

Pengju Li, et al. “A Nomogram Based on TFE3 IHC Results and Clinical Factors as a Preliminary Screening Scheme for TFE3‐rearranged Renal Cell Carcinoma.” Cancer Medicine, vol. 13, no. 5, Mar. 2024. EBSCOhost, https://doi.org/10.1002/cam4.6813.

APA

Pengju Li, Quanhui Xu, Minyu Chen, Jiangquan Zhu, Yinghan Wang, Mukhtar A. Mumin, Kangbo Huang, Zeying Jiang, Hui Liang, Qiong Deng, Zhu Wang, Bing Liao, Wenfang Chen, Yun Cao, Jiazheng Cao, & Junhang Luo. (2024). A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3‐rearranged renal cell carcinoma. Cancer Medicine, 13(5). https://doi.org/10.1002/cam4.6813

Chicago

Pengju Li, Quanhui Xu, Minyu Chen, Jiangquan Zhu, Yinghan Wang, Mukhtar A. Mumin, Kangbo Huang, et al. 2024. “A Nomogram Based on TFE3 IHC Results and Clinical Factors as a Preliminary Screening Scheme for TFE3‐rearranged Renal Cell Carcinoma.” Cancer Medicine 13 (5). doi:10.1002/cam4.6813.